pharma news today obesity drugs glp-1 october 2025 trends 2025: real-world data, patient outcomes & future therapies Drugmakers are racing to find

Find out if Kaiser covers Semaglutide (Wegovy), reasons for denial, how to secure coverage, costs without insurance, and common FAQs in this informative guide.

Consumers using the meds were more likely to be between 40 and 64 years of age

Individuals should consult their clinicians regarding diagnosis or treatment decisions

The poll finds 12% of adults report having taken one of these GLP-1 drugs, which include Ozempic, Webovy and Mounjaro

PlexusDx offers compounded semaglutide and tirzepatide options starting as low as $129 per month, with no insurance requirement or membership fees

Formulated for easy, consistent use, they fit seamlessly into your daily habits